Therapeutic use of butyrylcholinesterase for cocaine intoxication

Toxicology and Applied Pharmacology

Volumn 145, Issue 2, 1997, Pages 372-380

  Mattes, C E ^a,b   Lynch, T J ^a,d   Singh, A ^b   Bradley, R M ^a   Kellaris, P A ^a   Brady, R O ^c   Dretchen, K L ^b  

^a Pharmavene Inc   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c Office of Blood Research and Review ^*  (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE; COCAINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DETOXIFICATION; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG TOXICITY; ENZYME THERAPY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; RAT;

ANIMALIA; FELIS CATUS;

EID: 0031214055     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8188     Document Type: Article

References (37)

1. Absuda G. M., Abukhalaf I. K., Alford D. D., Vinzon-Bauista I., Pramanik A. K., Ansari N. A., Manno J. E., Manno B. R. Solid-phase extraction and GC/MS quantitation of cocaine, ecgonine methylester, benzoylecgonine, and cocaethylene from meconium, whole blood, and plasma. J. Anal. Toxicol. 17:1993;353-358.
2. Ambre J., Fischman M., Ruo T-I. Urinary excretion of ecgonine methylester, a major metabolite of cocaine in humans. J. Anal. Toxicol. 8:1984;23-25.
3. Ambre J., Ruo T. I., Nelson J., Belkap S. Urinary excretion of cocaine, benzoylecgonine and ecgonine methylester in humans. J. Anal. Toxicol. 12:1988;301-306.
4. Benchimol A., Bartell H., Dessar K. B. Accelerated ventricular rhythm and cocaine abuse. Ann. Intern. Med. 88:1978;519-520.
5. Bouis P., Taccard G. Determination of cocaine and norcocaine in plasma and cell cultures using high-performance liquid chromatography. J. Chromatogr. 526:1990;447-459.
6. Brogan W. C., Lange R. A., Glamann B., Hillis L. D. Recurrent coronary vasoconstriction caused by intranasal cocaine: Possible role for metabolites. Ann. Intern. Med. 116:1992;556-561.
7. Browne S. P., Slaughter E. A., Couch R. A., McLean A. M., Rudnic E. M. The influence of BChE concentration on the in vitro hydrolysis of cocaine in human plasma. Pharmacol. Res. 12:1995;S274.
8. Crumb W. J., Clarkson C. W. Characterization of the sodium channel blocking properties of the major metabolites of cocaine in single cardiac myocytes. J. Pharmacol. Exp. Ther. 261:1992;910-917.
9. Crumb W. J., Kadowitz P. J., Xu Y. Q., Clarkson C. W. Electrocardiographic evidence for cocaine cardiotoxicity in cat. Can. J. Physiol. Pharmacol. 68:1990;622-625.
10. DeVane C. L., Simpkins J. W., Miller R. L., Braun S. B. Tissue distribution of cocaine in the pregnant rat. Life Sci. 45:1989;1271-1276.
11. Devenyi P. Cocaine complications and pseudocholinesterase. Ann. Intern. Med. 110:1989;167-168.
12. Dietz A. A., Rubinstein H. M., Lubrano T. Colorimetric determination of serum cholinesterase and its genetic variants by the propionylthiocholine-dithiobis(nitrobenzoic) acid procedure. Clin. Chem. 19:1973;1309-1313.
13. Fraker T. D., Temesy-Armos P. N., Brewster P. S., Wilkerson R. D. Interaction of propranolol, verapamil, and nifedipine on the myocardial depressant effect of cocaine. J. Cardiovasc. Pharmacol. 25:1995;579-586.
14. Hale S. L., Lehmann M. H., Kloner R. A. Electrocardiographic abnormalities after acute administration cocaine in the rat. Am. J. Cardiol. 63:1989;1529-1530.
15. Hawks R. L., Kopin I. J., Colburn R. W., Thoa N. B. Norcocaine: A pharmacologically active metabolite of cocaine found in brain. Life Sci. 15:1974;2189-2195.
16. Herschman Z., Aaron C. Prolongation of cocaine effect. Anesthesiology. 74:1991;631-632.
17. Hoffman R. S., Henry G. C., Howland M. A., Weisman R. S., Weil L., Goldfrank L. R. Association between life-threatening cocaine toxicity and plasma cholinesterse activity. Ann. Emerg. Med. 21:1992;247-253.
18. Hollander J. E. The management of cocaine-associated myocardial ischemia. N. Engl. J. Med. 333:1995;1267-1272.
19. Inaba T., Stewart D. J., Kalow W. Metabolism of cocaine in man. Clin. Pharmacol. Ther. 23:1978;547-552.
20. Isenschmid D. S., Fischman M. W., Foltin R. W., Caplan Y. H. Concentration of cocaine and metabolites in plasma of humans following administration and smoking of cocaine. J. Anal. Toxicol. 16:1992;311-314.
21. Jonsson S., O'Meara M., Young J. B. Acute cocaine poisoning: Importance of treating seizures and acidosis. Am. J. Med. 75:1983;1061-1064.
22. Kabas J. S., Blanchard S. M., Matsuyama Y., Long J. D., Hoffman G. W. Jr., Ellinwood E. H., Smith P. K., Strauss H. C. Cocaine-mediated impairment of cardiac conduction in the dog: A potential mechanism for sudden death after cocaine. J. Pharmacol. Exp. Ther. 252:1990;185-191.
23. Kambam J., Mets B., Hickman R. M., Janicki P., James M. F. M., Fuller B., Kirsch R. E. The effects of inhibition of plasma cholinesterase and hepatic microsomal enzyme activity on cocaine, benzoylecgonine, ecgonine methylester and norcocaine blood level in pigs. J. Lab. Clin. Med. 120:1992;323-328.
24. Katz A. A., Hoffman R. S., Silverman R. A. Phenytoin toxicity from smoking crack cocaine adulterated with phenytoin. Ann. Emerg. Med. 22:1993;1485-1487.
25. Konkol R. J., Erickson B. A., Doerr J. K., Hoffman R. G., Madden J. A. Seizures induced by the cocaine metabolite benzoylecgonine in rats. Epilepsia. 33:1992;420-427.
26. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
27. Lockridge O., La Du B. N. Comparison of atypical and usual human serum cholinesterase. J. Biol. Chem. 253:1978;361-366.
28. Lynch T. J., Mattes C. E., Singh A., Bradley R. M., Brady R. O., Dretchen K. L. Cocaine detoxification by human plasma butyrylcholinestrase. Toxicol. Appl. Pharmacol. 145:1997;363-371.
29. Madden J. A., Powers R. H. Effect of cocaine metabolites on cerebral arteries in vitro. Life Sci. 47:1991;1109-1114.
30. Mattes C., Bradley R., Slaughter E., Browne S. Cocaine and butyrylcholinesterase (BChE): Determination of enzyme parameters. Life Sci. 58:1996;PL257-PL262.
31. Merigan K. S., Park L. J., Leeper K. V., Browning R. G., Giometi R. Adrenergic crisis from crack cocaine ingestion: Report of five cases. J. Emerg. Med. 12:1994;485-490.
32. Nanji A. A., Filipenko J. D. Asystole and ventricular fibrillation associated with cocaine intoxication. Chest. 85:1984;132-133.
33. Nelson L., Hoffman R. S. How to manage acute MI when the cause is cocaine. J. Crit. Ill. 10:1995;39-43.
34. Om A., Ellah S., Ornato J. P., Picone C., Theogaraj J., Corretjer G. P., Vetrovec G. W. Medical complications of cocaine: Possible relationship to low plasma cholinesterase enzyme. Am. Heart J. 125:1993;1114-1117.
35. Sand I. C., Brody S. L., Wrenn K. D., Slovis C. M. Experience with esmolol for the treatment of cocaine-associated cardiovascular complications. Am. J. Emerg. Med. 9:1991;161-163.
36. Stewart D. J., Inaba T., Tang B. K., Kalow W. Hydrolysis of cocaine in human plasma by cholinesterase. Life Sci. 20:1977;1557-1564.
37. Winecoff A. P., Hariman R. J., Grawe J. J., Wang Y., Bauman J. L. Reversal of the electrocardiographic effects of cocaine by lidocaine. Pharmacotherapy. 14:1994;698-703.